Abiopharma

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: Change in interest of Director - Ow Chio Kiat

Genco Shipping & Trading Limited Highlights Recommendations from Leading Independent Proxy Advisory Firms Glass Lewis and Egan-Jones that Shareholders Vote “FOR” ALL of Genco’s Director Nominees

SurgePays Signs Master Services Agreement with BrandRap to Build Artificial Intelligence (AI) Decisioning Engine to Drive Higher Revenue Per Subscriber

JCDecaux : Déclaration mensuelle d’actions et de droits de vote au 31 mai 2026

SEGG Media Opens Exclusive First Access to Sports.com Predict

Cosmos Health Continues U.S. Expansion with Launch of Oliv18, Targeting Cardiovascular and Antioxidant Categories

Clinical trial NCT04644770 updates: 1. completion date: 2027-01-15 → 2026-12-08 2. primary completion date: 2027-01-15 → 2026-12-08

Clinical trial NCT06260163 updates: 1. completion date: 2028-08-14 → 2027-04-28 2. primary completion date: 2028-05-22 → 2027-02-10

Clinical trial NCT07525141: start date: 2026-05-18 → 2026-05-26.

Clinical trial NCT07602088: start date: 2026-06-01 → 2026-05-18.